SCHEMBL6133895

SCHEMBL6133895

C1=C(c2c[nH]c3cc(OCc4ccccc4)ccc23)CCNC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
KDM4E B2RXH2 2/20 0.58
MAPT P10636 2/20 0.58
HSD17B10 Q99714 2/20 0.58
HTR2C P28335 2/20 0.58
DRD2 P14416 2/20 0.58
ALOX15 P16050 1/20 0.58
HTR6 P50406 3/20 0.54
MEN1 O00255 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
HTR1D P28221 1/20 0.54
MAPK1 P28482 1/20 0.54
BRCA1 P38398 1/20 0.54
KMT2A Q03164 1/20 0.54
IMPDH2 P12268 1/20 0.52
PRMT5 O14744 3/20 0.49
HPGD P15428 1/20 0.49
MDH2 P40926 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705100 0.91 KDM4E (0.66) ALDH1A1KDM4EMAPTHSD17B10HTR2C
SCHEMBL7864917 0.80 HTR6 (0.81) ALDH1A1KDM4EMAPTHSD17B10HTR2C
SCHEMBL31640013 0.79 HTR6 (0.52) HTR2CHTR6PRMT5
SCHEMBL16801767 0.79 KDM4E (0.56) ALDH1A1KDM4EMAPTHSD17B10HTR2C
Hydrochloric Acid SCHEMBL29923085 0.78 PRMT5 (0.62) MAPTHTR2CHTR6CYP1A2PRMT5
SCHEMBL12874806 0.77 KDM4E (0.48) ALDH1A1KDM4EMAPTHSD17B10HTR2C
SCHEMBL4672600 0.77 PRMT5 (0.64) MAPTHTR2CHTR6CYP1A2PRMT5
SCHEMBL16801579 0.76 PRMT5 (0.53) ALDH1A1MAPTDRD2PRMT5HPGD
SCHEMBL29379037 0.75 KDM4E (1.00) ALDH1A1KDM4EMAPTHSD17B10HTR2C
SCHEMBL653742 0.75 KDM4E (1.00) ALDH1A1KDM4EMAPTHSD17B10HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050245540-A1 New methods FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245540-A1 New methods TGFB1, TGFBR1, TGFB2 ALDH1A1 885/4885KDM4E 3172/4885MAPT 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.